Exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers

The Pharmacogenomics Journal
E W ChuaM A Kennedy

Abstract

Preferential conversion of azathioprine or 6-mercaptopurine into methylated metabolites is a major cause of thiopurine resistance. To seek potentially Mendelian causes of thiopurine hypermethylation, we recruited 12 individuals who exhibited extreme therapeutic resistance while taking azathioprine or 6-mercaptopurine and performed whole-exome sequencing (WES) and copy-number variant analysis by array-based comparative genomic hybridisation (aCGH). Exome-wide variant filtering highlighted four genes potentially associated with thiopurine metabolism (ENOSF1 and NFS1), transport (SLC17A4) or therapeutic action (RCC2). However, variants of each gene were found only in two or three patients, and it is unclear whether these genes could influence thiopurine hypermethylation. Analysis by aCGH did not identify any unusual or pathogenic copy-number variants. This suggests that if causative mutations for the hypermethylation phenotype exist they may be heterogeneous, occurring in several different genes, or they may lie within regulatory regions not captured by WES. Alternatively, hypermethylation may arise from the involvement of multiple genes with small effects. To test this hypothesis would require recruitment of large patient samples...Continue Reading

References

Jan 1, 1992·European Journal of Clinical Pharmacology·L Lennard
Jun 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J L JohnsonS K Wadman
Apr 1, 1981·Digestive Diseases and Sciences·J E Lennard-Jones
Jan 1, 1994·Clinical Pharmacology and Therapeutics·H L McLeodW E Evans
Nov 7, 1996·Chemical Reviews·Russ Hille
Jun 21, 2005·Genome Research·Gregory M CooperArend Sidow
Jul 29, 2005·Journal of Gastroenterology and Hepatology·Richard B Gearry, Murray L Barclay
Sep 20, 2005·Genome Research·Belinda GiardineAnton Nekrutenko
Sep 27, 2006·The Pharmacogenomics Journal·R L RobertsM A Kennedy
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jun 9, 2009·Alimentary Pharmacology & Therapeutics·M A SmithJ D Sanderson
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Sep 10, 2009·Science Signaling·Jonathan D HumphriesMartin J Humphries
Sep 15, 2009·Clinical Biochemistry·Natasa Karas-KuzelickiIrena Mlinaric-Rascan
Dec 3, 2009·Pharmacogenetics and Genomics·Gianluigi ZazaRuss B Altman
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Apr 1, 2010·Nature Methods·Gregory M CooperDeborah A Nickerson
Oct 29, 2010·Nature·Gonçalo R AbecasisGil A McVean
Mar 11, 2011·Trends in Molecular Medicine·Yijing HeHoward L McLeod
Mar 31, 2012·American Journal of Physiology. Cell Physiology·Natsuko TogawaYoshinori Moriyama
Aug 1, 2012·Human Molecular Genetics·Gabriele StoccoWilliam E Evans
Nov 7, 2012·Nature·UNKNOWN 1000 Genomes Project ConsortiumGil A McVean
Nov 15, 2012·Pharmacogenomics·John A DuleyJennifer H Martin
Dec 21, 2012·International Journal of Clinical Practice·M SmithJ Sanderson
Jun 12, 2013·Molecular Psychiatry·A K TiwariH Y Meltzer
Jun 19, 2013·Biochemical Pharmacology·P A BlakerA M Marinaki
Jul 3, 2013·Clinical Chemistry·Laurent ChouchanaMarie-Anne Loriot
Oct 22, 2013·Pharmacogenetics and Genomics·Britt I DrögemöllerLouise Warnich
Nov 1, 2013·Nucleic Acids Research·Jeffrey R MacDonaldStephen W Scherer
Nov 21, 2013·Nucleic Acids Research·UNKNOWN UniProt Consortium

❮ Previous
Next ❯

Citations

Oct 27, 2015·International Journal of Cardiology·P G BridgmanM A Kennedy
May 5, 2017·Pharmacogenomics·Zeina N Al-MahayriBassam R Ali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.